8 Einträge gefunden

1. Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 Infections

   1. Dietz, Julia
   2. Spengler, Ulrich
   3. Müllhaupt, Beat
   4. Schulze Zur Wiesch, Julian
   5. Piecha, Felix
   6. Mauss, Stefan
   7. Seegers, Barbara

   2021 - Forschungsinformationssystem des UKE
2. Treatment outcomes in hepatitis C virus genotype 1a infected patients with and without baseline NS5A resistance-associated substitutions

   1. Dietz, Julia
   2. Vermehren, Johannes
   3. Matschenz, Katrin
   4. Buggisch, Peter
   5. Klinker, Hartwig
   6. Schulze Zur Wiesch, Julian
   7. Hinrichsen, Holger

   2020 - Forschungsinformationssystem des UKE
3. Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals

   1. Dietz, Julia
   2. Susser, Simone
   3. Vermehren, Johannes
   4. Peiffer, Kai-Henrik
   5. Grammatikos, Georgios
   6. Berger, Annemarie
   7. Ferenci, Peter

   2018 - Forschungsinformationssystem des UKE
4. The determination of GGT is the most reliable predictor of nonresponsiveness to interferon-alpha based therapy in HCV type-1 infection.

   1. Weich, Viola
   2. Herrmann, Eva
   3. Chung, Tje Lin
   4. Sarrazin, Christoph
   5. Hinrichsen, Holger
   6. Buggisch, Peter
   7. Gerlach, Tilman

   2011 - Forschungsinformationssystem des UKE
5. Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients.

   1. Berg, Thomas
   2. Weich, Viola
   3. Teuber, Gerlinde
   4. Klinker, Hartwig
   5. Möller, Bernd
   6. Rasenack, Jens
   7. Hinrichsen, Holger

   2009 - Forschungsinformationssystem des UKE
6. Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infection.

   1. von Wagner, Michael
   2. Hofmann, Wolf Peter
   3. Teuber, Gerlinde
   4. Berg, Thomas
   5. Goeser, Tobias
   6. Spengler, Ulrich
   7. Hinrichsen, Holger

   2008 - Forschungsinformationssystem des UKE
7. Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection.

   1. Halangk, Juliane
   2. Sarrazin, Christoph
   3. Neumann, Konrad
   4. Puhl, Gero
   5. Mueller, Tobias
   6. Teuber, Gerlinde
   7. Klinker, Hartwig

   2008 - Forschungsinformationssystem des UKE
8. Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial.

   1. Kronenberger, Bernd
   2. Berg, Thomas
   3. Herrmann, Eva
   4. Hinrichsen, Holger
   5. Gerlach, Tilman
   6. Buggisch, Peter
   7. Spengler, Ulrich

   2007 - Forschungsinformationssystem des UKE